• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
(67/68)Galmydar: A metalloprobe for monitoring breast cancer resistance protein (BCRP)-mediated functional transport activity.(67/68)加尔米达尔:一种用于监测乳腺癌耐药蛋白(BCRP)介导的功能性转运活性的金属探针。
Nucl Med Biol. 2016 Mar;43(3):191-7. doi: 10.1016/j.nucmedbio.2015.12.001. Epub 2015 Dec 8.
2
Ga[Ga]-Galmydar: Biodistribution and radiation dosimetry studies in rodents.镓[镓]-甘氨酰谷氨酰二肽:啮齿动物的体内分布和辐射剂量学研究。
Nucl Med Biol. 2018 Apr;59:29-35. doi: 10.1016/j.nucmedbio.2017.11.008. Epub 2017 Dec 1.
3
Enhanced Positron Emission Tomography Imaging of β-Amyloid through Focused Ultrasound-Mediated Gallium-68 Radiotracer Delivery across the Blood-Brain Barrier.通过聚焦超声介导的镓-68放射性示踪剂穿过血脑屏障实现β-淀粉样蛋白的增强正电子发射断层扫描成像。
ACS Chem Neurosci. 2025 Aug 6;16(15):3070-3081. doi: 10.1021/acschemneuro.5c00476. Epub 2025 Jul 28.
4
Neisseria meningitidis regulates P-glycoprotein transporter activity in brain endothelial cells via sphingosine 1-phosphate receptor 1.脑膜炎奈瑟菌通过鞘氨醇-1-磷酸受体1调节脑内皮细胞中的P-糖蛋白转运体活性。
Fluids Barriers CNS. 2025 Jul 22;22(1):78. doi: 10.1186/s12987-025-00687-0.
5
A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants.一项评估核黄素作为健康受试者中乳腺癌耐药蛋白替代标志物适用性的初步研究。
J Pharmacol Exp Ther. 2024 Jul 18;390(2):162-173. doi: 10.1124/jpet.123.002015.
6
Ga-68 Pentixafor PET/CT in multiple myeloma and its correlation with clinical parameters: institutional pilot study.镓-68喷替沙福PET/CT在多发性骨髓瘤中的应用及其与临床参数的相关性:机构性初步研究
Ann Nucl Med. 2025 Mar 7. doi: 10.1007/s12149-025-02036-5.
7
Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs.艾拉司群在卵巢癌的二维和三维细胞培养模型中抑制乳腺癌耐药蛋白(BCRP)的蛋白活性,并使细胞对细胞毒性药物重新敏感。
Int J Mol Sci. 2025 Jun 17;26(12):5800. doi: 10.3390/ijms26125800.
8
Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation.在一项非临床研究中,口服 SARS-CoV-2 3C 样蛋白酶抑制剂恩赛特韦的口服吸收中 P-糖蛋白和 BCRP 的参与程度极小。
J Pharm Sci. 2024 Sep;113(9):2871-2878. doi: 10.1016/j.xphs.2024.06.009. Epub 2024 Jun 15.
9
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
10
68Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity.68Ga-Galmydar:一种用于非侵入性检测多柔比星诱导心脏毒性的 PET 成像示踪剂。
PLoS One. 2019 May 23;14(5):e0215579. doi: 10.1371/journal.pone.0215579. eCollection 2019.

引用本文的文献

1
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity.正电子发射断层扫描放射性药物在化疗诱导性心脏毒性成像中的应用。
Curr Cardiol Rep. 2020 Jun 19;22(8):62. doi: 10.1007/s11886-020-01315-z.
2
ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas.血脑界面的ABC转运蛋白、其研究模型及在胶质瘤中的药物递送意义
Pharmaceutics. 2019 Dec 23;12(1):20. doi: 10.3390/pharmaceutics12010020.
3
68Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity.68Ga-Galmydar:一种用于非侵入性检测多柔比星诱导心脏毒性的 PET 成像示踪剂。
PLoS One. 2019 May 23;14(5):e0215579. doi: 10.1371/journal.pone.0215579. eCollection 2019.
4
Live-cell fluorescence imaging: assessment of thioflavin T uptake in human epidermal carcinoma cells.活细胞荧光成像:人表皮癌细胞中硫黄素T摄取的评估
Medchemcomm. 2018 Apr 20;9(6):946-950. doi: 10.1039/c8md00101d. eCollection 2018 Jun 1.
5
Ga-metalloprobes: monitoring the impact of geometrical isomers on accumulation profiles in rat cardiomyoblasts and human breast carcinoma cells.镓金属探针:监测几何异构体对大鼠心肌母细胞和人乳腺癌细胞中积累分布的影响
Medchemcomm. 2016 Nov 9;8(1):158-161. doi: 10.1039/c6md00474a. eCollection 2017 Jan 1.

本文引用的文献

1
A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion.一种用于心肌灌注PET成像的由发生器产生的镓-68放射性药物。
PLoS One. 2014 Oct 29;9(10):e109361. doi: 10.1371/journal.pone.0109361. eCollection 2014.
2
Interrogation of multidrug resistance (MDR1) P-glycoprotein (ABCB1) expression in human pancreatic carcinoma cells: correlation of 99mTc-Sestamibi uptake with western blot analysis.人胰腺癌细胞中多药耐药(MDR1)P-糖蛋白(ABCB1)表达的检测:99mTc-司他米比摄取与蛋白质印迹分析的相关性
Nucl Med Commun. 2014 Oct;35(10):1067-70. doi: 10.1097/MNM.0000000000000158.
3
(R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.(R)-[(11)C]维拉帕米可被鼠和人血脑屏障上的 P-糖蛋白选择性转运,而不受 MRP1 和 BCRP 的影响。
Nucl Med Biol. 2013 Oct;40(7):873-8. doi: 10.1016/j.nucmedbio.2013.05.012. Epub 2013 Jul 8.
4
Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier.11C-他利克索和 11C-埃拉西达与血脑屏障上的 P-糖蛋白和乳腺癌耐药蛋白的相互作用。
J Nucl Med. 2013 Aug;54(8):1181-7. doi: 10.2967/jnumed.112.118232. Epub 2013 Jul 5.
5
A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier.一种用于可视化血脑屏障中乳腺癌耐药蛋白功能的新型 PET 方案。
J Cereb Blood Flow Metab. 2012 Nov;32(11):2002-11. doi: 10.1038/jcbfm.2012.112. Epub 2012 Jul 25.
6
Intestinal ischemia-reperfusion increases efflux for uric acid via paracellular route in the intestine, but decreases that via transcellular route mediated by BCRP.肠缺血再灌注通过肠细胞旁途径增加尿酸的外排,但通过 BCRP 介导的肠细胞内途径减少尿酸的外排。
J Pharm Pharm Sci. 2012;15(2):295-304. doi: 10.18433/j3w896.
7
Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice.从 P-糖蛋白(P-gp)、乳腺癌耐药蛋白(Bcrp)和 P-gp/Bcrp 敲除小鼠中分离的脑毛细血管内皮细胞中转运蛋白表达的定量蛋白质组学。
Drug Metab Dispos. 2012 Jun;40(6):1164-9. doi: 10.1124/dmd.112.044719. Epub 2012 Mar 8.
8
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.乳腺癌耐药蛋白(BCRP/ABCG2):其在多药耐药中的作用及其基因表达的调控
Chin J Cancer. 2012 Feb;31(2):73-99. doi: 10.5732/cjc.011.10320. Epub 2011 Nov 18.
9
Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.人脑微血管中转运体和药物代谢酶的转录组学和定量蛋白质组学分析。
Mol Pharm. 2011 Aug 1;8(4):1332-41. doi: 10.1021/mp200129p. Epub 2011 Jul 8.
10
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors.人血脑屏障转运体和受体的定量靶向绝对蛋白质组学。
J Neurochem. 2011 Apr;117(2):333-45. doi: 10.1111/j.1471-4159.2011.07208.x. Epub 2011 Feb 25.

(67/68)加尔米达尔:一种用于监测乳腺癌耐药蛋白(BCRP)介导的功能性转运活性的金属探针。

(67/68)Galmydar: A metalloprobe for monitoring breast cancer resistance protein (BCRP)-mediated functional transport activity.

作者信息

Sivapackiam Jothilingam, Harpstrite Scott E, Prior Julie L, Mattingly Stephen, Sharma Vijay

机构信息

ICCE Institute, Molecular Imaging Center, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.

ICCE Institute, Molecular Imaging Center, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Students and Teachers As Research Scientists (STARS), Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Nucl Med Biol. 2016 Mar;43(3):191-7. doi: 10.1016/j.nucmedbio.2015.12.001. Epub 2015 Dec 8.

DOI:10.1016/j.nucmedbio.2015.12.001
PMID:26924499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12369548/
Abstract

INTRODUCTION

For stratification of chemotherapeutic choices, radiopharmaceuticals capable of imaging breast cancer resistance protein (BCRP/ABCG2)-mediated functional transport are desired. To accomplish this objective, Galmydar, a fluorescent and moderately hydrophobic Ga(III) cationic complex and its (67/68)Ga-radiolabeled counterparts were interrogated in HEK293 cells stably transfected with BCRP and their WT counterparts transfected with empty vector. Additionally, the sensitivity and specificity of (68)Ga-Galmydar to evaluate functional expression of BCRP at the blood-brain barrier (BBB) was investigated in gene-knockout mdr1a/1b(-/-) (double knockout, dKO) and mdr1a/1b(-/-)ABCG2(-/-) (triple knockout, tKO) mouse models.

METHODS

For radiotracer uptake assays and live cell fluorescence imaging, either (67)Ga-Galmydar or its unlabeled counterpart was incubated in HEK293 cells transfected with BCRP (HEK293/BCRP) and their WT counterparts at 37°C under a continuous flux of CO2 (5%) in the presence or absence of Ko143, a potent BCRP antagonist, and cellular uptake was measured to assess the sensitivity of Galmydar to probe BCRP-mediated functional transport activity in cellulo. For assessing the potential of Galmydar to enable diagnostic imaging of targeted tissues in vivo, the (67)Ga-radiolabeled counterpart was incubated in either human serum albumin or human serum at 37°C and the percentage of unbound (67)Ga-Galmydar was determined. To evaluate the sensitivity of (68)Ga-Galmydar for molecular imaging of BCRP-mediated efflux activity in vivo, microPET/CT brain imaging was performed in dKO and tKO mice and their age-matched WT counterparts, 60min post-intravenous injection.

RESULTS

(67)Ga-Galmydar shows uptake profiles in HEK293 cells inversely proportional to BCRP expression, and antagonist (Ko143) induced accumulation in HEK293/BCRP cells, thus indicating target sensitivity and specificity. Furthermore, employing the fluorescent characteristics of Galmydar, optical imaging in HEK293/BCRP cells shows an excellent correlation with the radiotracer cellular accumulation data. (67)Ga-Galmydar shows > 85% unbound fraction and presence of parental compound in human serum. Finally, microPET/CT imaging shows higher retention of (68)Ga-Galmydar in brains of dKO and tKO mice compared to their age-matched WT counterparts, 60min post-intravenous tail-vein injection.

CONCLUSIONS

Combined data indicate that Galmydar could provide a template scaffold for development of a PET tracer for imaging BCRP-mediated functional transport activity in vivo.

摘要

引言

为了对化疗选择进行分层,需要能够对乳腺癌耐药蛋白(BCRP/ABCG2)介导的功能性转运进行成像的放射性药物。为实现这一目标,在稳定转染了BCRP的HEK293细胞及其转染空载体的野生型对应细胞中研究了Galmydar(一种荧光且具有适度疏水性的Ga(III)阳离子复合物)及其(67/68)Ga放射性标记的类似物。此外,在基因敲除mdr1a/1b(-/-)(双敲除,dKO)和mdr1a/1b(-/-)ABCG2(-/-)(三敲除,tKO)小鼠模型中研究了(68)Ga-Galmydar评估血脑屏障(BBB)处BCRP功能表达的敏感性和特异性。

方法

对于放射性示踪剂摄取测定和活细胞荧光成像,将(67)Ga-Galmydar或其未标记的类似物在37°C、5% CO2连续气流存在或不存在强效BCRP拮抗剂Ko143的条件下,与转染了BCRP的HEK293细胞(HEK293/BCRP)及其野生型对应细胞一起孵育,并测量细胞摄取以评估Galmydar在细胞内探测BCRP介导的功能性转运活性的敏感性。为了评估Galmydar在体内对靶向组织进行诊断成像的潜力,将(67)Ga放射性标记的类似物在37°C下与人血清白蛋白或人血清一起孵育,并测定未结合的(67)Ga-Galmydar的百分比。为了评估(68)Ga-Galmydar在体内对BCRP介导的外排活性进行分子成像的敏感性,在静脉注射后60分钟,对dKO和tKO小鼠及其年龄匹配的野生型对应小鼠进行了microPET/CT脑成像。

结果

(67)Ga-Galmydar在HEK293细胞中的摄取情况与BCRP表达呈反比,拮抗剂(Ko143)诱导其在HEK293/BCRP细胞中积累,从而表明其对靶点的敏感性和特异性。此外,利用Galmydar的荧光特性,HEK293/BCRP细胞中的光学成像与放射性示踪剂细胞积累数据显示出极好的相关性。(67)Ga-Galmydar在人血清中的未结合分数>85%,且存在亲本化合物。最后,microPET/CT成像显示,在尾静脉注射后60分钟,与年龄匹配的野生型对应小鼠相比,dKO和tKO小鼠脑中(68)Ga-Galmydar的滞留更高。

结论

综合数据表明,Galmydar可为开发用于体内成像BCRP介导的功能性转运活性的PET示踪剂提供模板支架。